These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 38592132)
1. Arrhythmias and Device Therapies in Cardiac Amyloidosis. Bukhari S; Khan SZ; Ghoweba M; Khan B; Bashir Z J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592132 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of ventricular arrhythmias and role of implantable cardioverter-defibrillator in cardiac amyloidosis. Bukhari S; Khan B J Cardiol; 2023 May; 81(5):429-433. PubMed ID: 36894119 [TBL] [Abstract][Full Text] [Related]
4. Arrhythmias in Cardiac Amyloidosis: Challenges in Risk Stratification and Treatment. Cheung CC; Roston TM; Andrade JG; Bennett MT; Davis MK Can J Cardiol; 2020 Mar; 36(3):416-423. PubMed ID: 32145868 [TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465 [TBL] [Abstract][Full Text] [Related]
6. Association of Arrhythmias in Cardiac Amyloidosis and Cardiac Sarcoidosis. Ashraf I; Peck MM; Maram R; Mohamed A; Ochoa Crespo D; Kaur G; Malik BH Cureus; 2020 Aug; 12(8):e9842. PubMed ID: 32953349 [TBL] [Abstract][Full Text] [Related]
7. Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator. Kim EJ; Holmes BB; Huang S; Lugo R; Al Aboud A; Goodman S; Hung RR; Slosky D; Stevenson WG; Michaud GF; John RM Europace; 2020 Aug; 22(8):1216-1223. PubMed ID: 32514579 [TBL] [Abstract][Full Text] [Related]
8. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464 [TBL] [Abstract][Full Text] [Related]
9. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death]. Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820 [TBL] [Abstract][Full Text] [Related]
10. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia. Teo WS; Kam R; Tan A Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319 [TBL] [Abstract][Full Text] [Related]
11. Cardiac Implantable Electronic Devices: A Window Into the Evolution of Conduction Disease in Cardiac Amyloidosis. Rehorn MR; Loungani RS; Black-Maier E; Coniglio AC; Karra R; Pokorney SD; Khouri MG JACC Clin Electrophysiol; 2020 Sep; 6(9):1144-1154. PubMed ID: 32972550 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Kristen AV; Dengler TJ; Hegenbart U; Schonland SO; Goldschmidt H; Sack FU; Voss F; Becker R; Katus HA; Bauer A Heart Rhythm; 2008 Feb; 5(2):235-40. PubMed ID: 18242546 [TBL] [Abstract][Full Text] [Related]
13. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis. Hirakawa K; Takashio S; Marume K; Yamamoto M; Hanatani S; Yamamoto E; Sakamoto K; Izumiya Y; Kaikita K; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Yamashita Y; Ando Y; Tsujita K ESC Heart Fail; 2019 Feb; 6(1):122-130. PubMed ID: 30284755 [TBL] [Abstract][Full Text] [Related]